Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)
Clinical trial NCT03556384 · COMPLETED
Trial details
- NCT number
- NCT03556384
- Sponsor
- Adam Burgoyne, MD, PhD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-12
- Primary completion
- 2023-06-22
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.